Verve Therapeutics
VERV
#6795
Rank
โ‚ฌ0.46 B
Marketcap
5,52ย โ‚ฌ
Share price
11.24%
Change (1 day)
-57.40%
Change (1 year)

EPS for Verve Therapeutics (VERV)

EPS in 2023 (TTM): -3,00ย โ‚ฌ

According to Verve Therapeutics's latest financial reports the company's current EPS (TTM) is -3,05ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -2,81ย โ‚ฌ a decrease over its 2021 EPS that were of -2,43ย โ‚ฌ.

EPS history for Verve Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-3,00ย โ‚ฌ6.77%
2022-2,81ย โ‚ฌ15.54%
2021-2,43ย โ‚ฌ61.32%
2020-1,51ย โ‚ฌ